NEW YORK (GenomeWeb News) – Cepheid and the Knight Cancer Institute at Oregon Health & Science University said after the close of the market on Tuesday that they are collaborating to develop a menu of molecular diagnostic assays to run on Cepheid's GeneXpert platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.